|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Net sales | |||
| Cost of sales | |||
| Gross profit | |||
| Operating expenses: | |||
| Research and development | |||
| Sales and marketing | |||
| General and administrative | |||
| Total operating expenses | |||
| Operating income | |||
| Interest expense, net | |||
| Other income (expense), net | |||
| Income before income taxes | |||
| Provision for income taxes | |||
| Net income | |||
| Net income per share, basic (in dollars per share) | |||
| Net income per share, diluted (in dollars per share) | |||
| Weighted-average number of shares used in computing net income per share, basic (in shares) | |||
| Weighted-average number of shares used in computing net income per share, diluted (in shares) |
Loading...
